In murine T-cell-mediated demyelinating disease model of multiple sclerosis, venlafaxine significantly ameliorated clinical symptoms of the disease in association with a reduction of IL-12, TNF-α and IFN-γ [306]. The gene discussed is IFNG; the disease is multiple sclerosis.